Distinctive Profiles of Infection and Pathology in Hamsters Infected with Clostridium difficile Strains 630 and B1

被引:55
作者
Goulding, David [2 ]
Thompson, Harold [3 ]
Emerson, Jenny [4 ]
Fairweather, Neil F. [4 ]
Dougan, Gordon [2 ]
Douce, Gill R. [1 ]
机构
[1] Univ Glasgow, FBLS Glasgow Biomed Res Ctr, Div Infect & Immun, Glasgow G12 8QQ, Lanark, Scotland
[2] Wellcome Trust Genome Campus, Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England
[3] Univ Glasgow, Sch Vet, Div Pathol Sci, Bearsden Glasgow, Scotland
[4] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, London SW7 2AZ, England
基金
英国惠康基金; 英国生物技术与生命科学研究理事会;
关键词
TOXIN PRODUCTION; DISEASE; ANTIBODIES; MODEL; COLONIZATION; CLINDAMYCIN; PREVENTION; RESISTANT; COLITIS; BINDING;
D O I
10.1128/IAI.00551-09
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Currently, the Golden Syrian hamster is widely considered an important model of Clostridium difficile disease, as oral infection of this animal pretreated with antibiotics reproduces many of the symptoms observed in humans. Two C. difficile strains, B1 and 630, showed significant differences in the progression and severity of disease in this model. B1-infected hamsters exhibited more severe pathology and a shorter time to death than hamsters infected with 630. Histological changes in the gut did not correlate with absolute numbers of C. difficile bacteria, but there were clear differences in the distribution of bacteria within gut tissues. Light, scanning, and transmission electron microscopy revealed high numbers of B1 bacteria at the mucosal surface of the tissue, whereas 630 bacteria were more frequently associated with the crypt regions. Both B1 and 630 bacteria were frequently observed within polymorphonuclear leukocytes, although, interestingly, a space frequently separated B1 bacteria from the phagosome wall, a phenomenon not observed with 630. However, pilus-like structures were detected on 630 located in the crypts of the gut tissue. Furthermore, B1 bacteria, but not 630 bacteria, were found within nonphagocytic cells, including enterocytes and muscle cells.
引用
收藏
页码:5478 / 5485
页数:8
相关论文
共 35 条
[1]   Clinical features of Clostridium difficile-associated infections and molecular characterization of strains:: Results of a retrospective study, 2000-2004 [J].
Barbut, Frederic ;
Gariazzo, Beatrice ;
Bonne, Laetitia ;
Lalande, Valerie ;
Burghoffer, Beatrice ;
Luiuz, Ralucca ;
Petit, Jean-Claude .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2007, 28 (02) :131-139
[2]   CLINDAMYCIN-ASSOCIATED COLITIS DUE TO A TOXIN-PRODUCING SPECIES OF CLOSTRIDIUM IN HAMSTERS [J].
BARTLETT, JG ;
ONDERDONK, AB ;
CISNEROS, RL ;
KASPER, DL .
JOURNAL OF INFECTIOUS DISEASES, 1977, 136 (05) :701-705
[3]   CLOSTRIDIUM-DIFFICILE - A SPECTRUM OF VIRULENCE AND ANALYSIS OF PUTATIVE VIRULENCE DETERMINANTS IN THE HAMSTER MODEL OF ANTIBIOTIC-ASSOCIATED COLITIS [J].
BORRIELLO, SP ;
KETLEY, JM ;
MITCHELL, TJ ;
BARCLAY, FE ;
WELCH, AR ;
PRICE, AB ;
STEPHEN, J .
JOURNAL OF MEDICAL MICROBIOLOGY, 1987, 24 (01) :53-64
[4]   Binding of Clostridium difficile surface layer proteins to gastrointestinal tissues [J].
Calabi, E ;
Calabi, F ;
Phillips, AD ;
Fairweather, NF .
INFECTION AND IMMUNITY, 2002, 70 (10) :5770-5778
[5]  
Cerquetti M, 2002, FEMS IMMUNOL MED MIC, V32, P211, DOI 10.1016/S0928-8244(01)00301-7
[6]   A Mouse Model of Clostridium difficile-Associated Disease [J].
Chen, Xinhua ;
Katchar, Kianoosh ;
Goldsmith, Jeffrey D. ;
Nanthakumar, Nanda ;
Cheknis, Adam ;
Gerding, Dale N. ;
Kelly, Ciaran P. .
GASTROENTEROLOGY, 2008, 135 (06) :1984-1992
[7]   THE BACTERIAL GLYCOCALYX IN NATURE AND DISEASE [J].
COSTERTON, JW ;
IRVIN, RT ;
CHENG, KJ .
ANNUAL REVIEW OF MICROBIOLOGY, 1981, 35 :299-324
[8]   Do fluoroquinolones predispose patients to Clostridium difficile associated disease?: A review of the evidence [J].
Deshpande, Abhishek ;
Pant, Chaitanya ;
Jain, Anil ;
Fraser, Thomas G. ;
Rolston, David D. K. .
CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (02) :329-333
[9]   Emergence and control of fluoroquinolone-resistant, toxin a-negative, toxin B-Positive Clostridium difficile [J].
Drudy, Denise ;
Harnedy, Norma ;
Fanning, Seamus ;
Hannan, Margaret ;
Kyne, Lorraine .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2007, 28 (08) :932-940
[10]   Effect of metronidazole on growth and toxin production by epidemic Clostridium difficile PCR ribotypes 001 and 027 in a human gut model [J].
Freeman, Jane ;
Baines, Simon D. ;
Saxton, Katie ;
Wilcox, Mark H. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (01) :83-91